Literature DB >> 8810945

Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis.

P Mondon1, C De Champs, A Donadille, P Ambroise-Thomas, R Grillot.   

Abstract

The diversity in virulence of different Aspergillus fumigatus strains was studied in an experimental murine model of invasive pulmonary aspergillosis (IPA) and the results were correlated with possession of a putative molecular marker of virulence. Seven strains from different patients with non-invasive or invasive aspergillosis and four environmental strains were typed by PCR with specific primers and scored as positive or negative, according to whether or not a 0.95-kb DNA fragment was amplified. Immunosuppressed mice were inoculated intranasally with A. fumigatus conidia from these different strains. The mortality curves revealed differences in virulence between the strains. The environmental strains produced a weaker infection than the strains from patients and the 0.95-kb-positive patient strains caused significantly higher mortality rates in mice than the 0.95-kb-negative patient strains. These findings support the hypothesis that certain isolates of A. fumigatus are more virulent than others and that their virulence appears to be associated with the 0.95-kb molecular marker.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810945     DOI: 10.1099/00222615-45-3-186

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

Review 1.  Alarmin(g) the innate immune system to invasive fungal infections.

Authors:  Alayna K Caffrey; Joshua J Obar
Journal:  Curr Opin Microbiol       Date:  2016-06-27       Impact factor: 7.934

Review 2.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Lung eosinophil recruitment in response to Aspergillus fumigatus is correlated with fungal cell wall composition and requires γδ T cells.

Authors:  Nansalmaa Amarsaikhan; Evan M O'Dea; Angar Tsoggerel; Steven P Templeton
Journal:  Microbes Infect       Date:  2017-05-25       Impact factor: 2.700

4.  Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.

Authors:  Kristin J Carpenter; Cory M Hogaboam
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.

Authors:  Emer P Reeves; C G M Messina; S Doyle; K Kavanagh
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

6.  Microsatellite markers for typing Aspergillus fumigatus isolates.

Authors:  E Bart-Delabesse; J F Humbert; E Delabesse; S Bretagne
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Dectin-1 Fc targeting of aspergillus fumigatus beta-glucans augments innate defense against invasive pulmonary aspergillosis.

Authors:  Polly E Mattila; Allison E Metz; Rekha R Rapaka; Lynne D Bauer; Chad Steele
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

8.  An evolutionary genomic approach reveals both conserved and species-specific genetic elements related to human disease in closely related Aspergillus fungi.

Authors:  Matthew E Mead; Jacob L Steenwyk; Lilian P Silva; Patrícia A de Castro; Nauman Saeed; Falk Hillmann; Gustavo H Goldman; Antonis Rokas
Journal:  Genetics       Date:  2021-06-24       Impact factor: 4.562

9.  Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates.

Authors:  Eleftheria Mavridou; Joseph Meletiadis; Pavol Jancura; Saiden Abbas; Maiken C Arendrup; Willem J G Melchers; Tom Heskes; Johan W Mouton; Paul E Verweij
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

10.  Isolate-dependent growth, virulence, and cell wall composition in the human pathogen Aspergillus fumigatus.

Authors:  Nansalmaa Amarsaikhan; Evan M O'Dea; Angar Tsoggerel; Henry Owegi; Jordan Gillenwater; Steven P Templeton
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.